Rilapladib | m-entrepreneurship.com

Product Name :
Rilapladib

Search keywords :
Rilapladib

drugId :
null

Target Vo:
Lipoprotein-associated phospholipase A2

Target Vo Short Name :
Lp-PLA2

Moa_Name:
Lipoprotein-associated phospholipase A2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Alzheimer Disease

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-IRE1 (Ser724) Antibody
SIRT2 Antibody
Beta casein Antibody: Beta casein Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-Beta casein polyclonal antibody. Beta casein Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, cow, sheep, goat, background without labeling.

Author: Betaine hydrochloride

Related Posts